Skip to main content
OGN logo

OGN

Organon & Co.

$13.89

0.11%

Trade Ideas Performance

Latest Closed Trade Idea

$13.89

0.11%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

4

Social

1

About

Events of Organon & Co. (OGN)

In the past six months, Organon & Co.'s stock price has been significantly impacted by the pending $11.75 billion acquisition by India-based Sun Pharma, announced in April 2026 and expected to close in early 2027, keeping the stock near its 52-week high of $13.88. The share price increased by 105.22% from November 3, 2025, to October 28, 2026. Other events include Organon's announcement of a quarterly dividend, positive interim Phase 3 study results for MIUDELLA (a hormone-free intrauterine device), and the FDA's acceptance of an sNDA for MIUDELLA with a decision anticipated in Q2 2027. The company reported a decrease in revenue but an increase in net income in its third-quarter 2026 results.

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)